Compare Sana Biotechnology Inc (SANA) vs Xylem, Inc. (XYL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Xylem, Inc. — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Xylem, Inc. trades at $120.79 (market cap $28.67B). The key difference: Xylem, Inc. is far larger — about 32.8× Sana Biotechnology Inc's market cap, and Xylem, Inc. pays a 1.43% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | XYL | |
|---|---|---|
Market Cap | $873.84M | $28.67B |
Sector | Health | Industrials |
52-Week High | $5.92 | $152.95 |
52-Week Low | $2.68 | $106.34 |
Enterprise Value | $848.03M | $29.92B |
Dividend Yield | — | 1.43% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Xylem, Inc.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →
